The BARDA DRIVe team is pleased to announce that the new, easy-to-use EZ BAA online Portal is now live as of April 23, 2019. This Portal will replace the existing PDF-based process, helping to improve the user experience, data integrity, and data security. The system will also streamline internal processes, helping DRIVe’s program teams continue to make awards in as few as 30 days.
Some 200 life sciences innovators, investors, and insiders crowded the offices of Mintz in downtown Boston last night as we announced the winners of the 8th annual M2D2 $200K Challenge. Out of a field of 19 Finalists, our judges selected 12 winners—a Challenge record.
With support from the Deshpande Foundation, three finalist startups from an incubator in Chennai, India were able to pitch their life sciences innovations in Lowell on March 27. Not only did they compete, but they were also able to immerse themselves first-hand in the burgeoning biotech ecosystem that’s making Boston and environs the talk of the innovation economy.
Dynocardia is 1 of 19 finalists chosen to pitch at the $200K Challenge Pitch-Off last Wednesday. Dynocardia’s ViTrack™ is the first-of-its-kind, standalone, cuff-less, wearable device for continuous non-invasive blood pressure monitoring.
Mohan Thanikachalam, CEO of Dynocardia, offers us an exclusive inside look behind the development of the ViTrackTM!
Top Row, Left to Right: Ragul Puhazhendi, Suha Sudharsanan, and Shiva Prakash of BuzzArk; Bottom Row, Left to Right: Vasanth Raghava, Prof S P Thyagarajan, Dr. T Mohanapriya, and Dr. Ramesh Sadasivan of BuzzArk
BuzzArk Simulations, chosen for their development of a VR simulation for natural orifice surgery procedures, is 1 of 20 MedTech startup finalists in the 8th annual M2D2 $200K Challenge.
Ragul Puhazhendi, Founder of Buzzark, offers us an exclusive inside look at the ups and downs behind the development of their simulation technology.
Margot Damaser, Full Staff and Professor at the Department of Biomedical Engineering for The Cleveland Clinic
The UroMonitor, a device to simplify and improve the diagnosis and treatment of stress urinary incontinence, was chosen as 1 of 20 finalists in the 8th annual M2D2 $200K Challenge.
Margot Damaser of Cleveland Clinicleads a team in the development of the UroMonitor. In this article, Margot offers some insight into the background of the innovative device and what it’s taken her team to get it this far!
James McNamara, Scientific Founder and CEO of Nuclease Probe Technologies
Nuclease Probe Technologies, one of 21 MedTech startup finalists in the 8th annual M2D2 $200K Challenge, was chosen for their development of a novel diagnostic for accurate and early detection of bloodstream infections (BSI’s).
We spoke with Scientific Founder and CEO, James McNamara, who shared the story of their innovation with us.